RIOX2 and lung carcinoma: Our previous reports revealed an elevated level of mdig protein or mRNA in human lung cancers that showed a substantial reduction in the level of H3K9me3 [2], which provided compensatory support to the observations showing decreased levels of H3K9me3 in mdig-overexpressing cells.